drugset / Trial / NCT00842933

Adrenal Insufficiency in Septic Shock

NCT00842933

Phase 4 Terminated 32 enrolled The Methodist Hospital Research Institute
RandomizedParallel-groupOpen-labelTreatment

Summary

Randomized controlled trial evaluating the duration of steroid replacement therapy in patients with adrenal insufficiency and septic shock. Patients will be randomized to receive either hydrocortisone 50 mg IV every six hours for seven days (control) or hydrocortisone 50 mg IV every six hours until 24 hours after achievement of hemodynamic stability (MAP \> 65 mm Hg off of vasopressors).

Timeline

Start
2007-05
Primary completion
2010-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified 50 mg Intravenous
Comparator Methylprednisolone Other / unclassified
Comparator Prednisone Other / unclassified